Abstract
A 65-year-old man developed 3-vessel stent thrombosis after percutaneous coronary intervention with aspirin and clopidogrel. Platelet tests revealed clopidogrel resistance, which resolved after changing clopidogrel to ticagrelor. Although routine platelet tests after stenting are not recommended, these tests may be considered to identify the cause of stent thrombosis and modify antiplatelet therapy.
Copyright © 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aspirin / therapeutic use
-
Clopidogrel / adverse effects*
-
Coronary Angiography
-
Dual Anti-Platelet Therapy
-
Humans
-
Male
-
Percutaneous Coronary Intervention
-
Platelet Aggregation Inhibitors / administration & dosage*
-
Platelet Aggregation Inhibitors / adverse effects
-
Stents / adverse effects*
-
Thrombosis / diagnostic imaging
-
Thrombosis / drug therapy*
-
Ticagrelor / therapeutic use*
Substances
-
Platelet Aggregation Inhibitors
-
Clopidogrel
-
Ticagrelor
-
Aspirin